Skip to main content

Advertisement

Log in

Pharmacist and Pharmacy Staff Experiences with Non-prescription (NP) Sale of Syringes and Attitudes Toward Providing HIV Prevention Services for Injection Drug Users (IDUs) in Providence, RI

Journal of Urban Health Aims and scope Submit manuscript

Abstract

Increased access to sterile syringes among injection drug users (IDUs) has been correlated with reduced syringe sharing. Many states, including Rhode Island, have legalized non-prescription (NP) sale of syringes in pharmacies. Previous studies have suggested that training pharmacists to provide HIV-related services to IDUs may be an important opportunity to engage IDUs and provide them with such services. However, it is not clear to what extent pharmacy staff are willing to expand their roles in providing services to IDUs who come in to purchase syringes. We recruited pharmacists and pharmacy staff from the 48 pharmacies indicating NP sale of syringes in the greater Providence, RI area, to participate in an online survey consisting of demographic information; views about the current syringe laws in Rhode Island; willingness to provide HIV-related services, including referral for HIV testing, substance use treatment, and medical and social services, to IDUs; and past experiences with IDU customers. One hundred and forty-six individuals completed the online survey (32 pharmacies, 114 pharmacy staff). Most participants were employed by chain pharmacies (92%). Most participants thought that pharmacies are important resources for IDU customers (77%) and that they would be willing to provide health and prevention information/referrals to IDU customers who purchase NP syringes (59%). With respect to willingness to offer HIV prevention-related services, access to confidential space and concern about personal safety had the strongest associations with willingness to provide HIV prevention services (OR, 4.3 and 0.1, respectively). As the nature of the retail pharmacy shifts, researchers, pharmacy executives, and health care officials can build upon the willingness of pharmacists and pharmacy staff in order to address the health needs of injection drug users and other underserved populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Academy for Educational Development. HIV prevention among drug users: a resource book for community planners and program managers. Washington DC: Academy for Educational Development; 1997.

    Google Scholar 

  2. Academy for Educational Development’s Center for Community-Based Health Strategies. A comprehensive approach: preventing blood-borne infections among IDUs. Dec. 2000: 1–76.

  3. Bourgois P, Lettiere M, Quesada J. Studying hidden populations—social misery and the sanctions of substance abuse: confronting HIV risk among homeless heroin addicts in San Francisco. Soc Probl. 1997; 44: 155-173.

    Article  Google Scholar 

  4. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 60. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.

  5. Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange’s closure. Public Health Rep. 1999; 114(5): 439-447.

    Article  CAS  PubMed  Google Scholar 

  6. Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington: National Academies Press; 1995.

    Google Scholar 

  7. Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc Wash. 2002; 42(6 Suppl 2): S58-S61.

    Article  PubMed  Google Scholar 

  8. Rich JD, Dickinson BP, Liu KL, et al. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S140-S141.

    PubMed  Google Scholar 

  9. R. I. Gen. Laws Ch. 21–218, § 4.04.

  10. Beckwith, C Moreira C, Aboshady H, Zaller N, Rich JD and Flanigan TP. A success story: HIV prevention for injection drug users in Rhode Island. Subst. Abuse Treat, Prev. Policy. 2006; 1: 34.

  11. Molitor F, Kuenneth C, Waltermeyer J, et al. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDs. 2005; 19: 406-412.

    Article  PubMed  Google Scholar 

  12. Porter J, Metzger D, Scotti R. Bridge to services: drug injectors’ awareness and utilization of drug user treatment and social service referrals, medical care, and HIV testing provided by needle exchange programs. Subst Use Misuse. 2002; 37: 1305-1330.

    Article  PubMed  Google Scholar 

  13. Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. J Subst Abuse. 2001; 13: 17-27.

    Article  CAS  PubMed  Google Scholar 

  14. Rich JD, Strong LL, Mehrotra M, Macalino G. Strategies to optimize the impact of needle exchange programs. AIDS Read. 2000; 10(7): 421-429.

    CAS  PubMed  Google Scholar 

  15. Nacopoulos AG, Lewtas AJ, Ousterhout MM. Syringe exchange programs: impact on injection drug users and the role of the pharmacist from a U.S. perspective. J Am Pharm Assoc. 2003; 50(2): 148-157.

    Article  Google Scholar 

  16. Centers for Disease Control and Prevention. Update: syringe exchange programs—United States. Morbidity and Mortality Weekly Report (MMWR). 2002; 54(27): 673–676. 7-15-2005.

  17. Lewis BA, Koester SK, Bush TW. Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc Wash. 2002; 42: S46-S51.

    Article  PubMed  Google Scholar 

  18. Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc Wash. 2002; 42: S62-S67.

    Article  PubMed  Google Scholar 

  19. Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc Wash. 2002; 42: S40-S45.

    Article  PubMed  Google Scholar 

  20. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient–physician relationship. JAMA. 1999; 282: 583-589.

    Article  CAS  PubMed  Google Scholar 

  21. Watters JK, Bieracki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989; 36: 416-430.

    Article  Google Scholar 

  22. Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists’ attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000; 77: 781-793.

    Article  CAS  PubMed  Google Scholar 

  23. Harbke CR, Fisher DG, Cagle HH, Trubatch BN, Fenaughty AM, Johnson ME. Telephone surveys of Alaskan pharmacists’ nonprescription needle-selling practices. J Urban Health. 2000; 77: 113-120.

    Article  CAS  PubMed  Google Scholar 

  24. Fuller CM, Galea S, Caceres W, et al. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97: 117-124.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grant numbers: P30-AI-42853 from the National Institutes of Health, Center for AIDS Research (NIH/CFAR); R21DA025010-01A1 from National Institute on Drug Abuse; and K24DA022112-01A from the National Institute on Drug Abuse.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nickolas Zaller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaller, N., Jeronimo, A., Bratberg, J. et al. Pharmacist and Pharmacy Staff Experiences with Non-prescription (NP) Sale of Syringes and Attitudes Toward Providing HIV Prevention Services for Injection Drug Users (IDUs) in Providence, RI. J Urban Health 87, 942–953 (2010). https://doi.org/10.1007/s11524-010-9503-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11524-010-9503-z

Keywords

Navigation